BackTaysha Gene Therapies Overview

Taysha Gene Therapies Total Liabilities

Latest total liabilities for TSHA: $78M.

Get informed when a big investor buys or sells

+ Follow
Total Liabilities
$78.06M
↓ 19.99% YoYΔ $-19.51M vs prior year quarter

Peer trimmed avg / median

Loading

Taysha Gene Therapies Total Liabilities History

Loading

Taysha Gene Therapies vs. peers: Total Liabilities Comparison

Loading

Taysha Gene Therapies Total Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Taysha Gene Therapies (TSHA) FAQ

Taysha Gene Therapies (TSHA) currently reports a total liabilities of $78M as of September 2026. That compares with $98M in the prior-year period — down 20.0% year over year. Use the charts on this page to explore Taysha Gene Therapies's total liabilities history and peer comparisons.

Taysha Gene Therapies's total liabilities decreased from $98M to $78M — a 20.0% year-over-year decrease (period ending September 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Taysha Gene Therapies reported $78M in total liabilities as of September 2026. That compares with $98M in the prior-year period — down 20.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total liabilities of $78M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Taysha Gene Therapies, and consider following TSHA for alerts when major investors trade the stock.

Taysha Gene Therapies is classified in the Healthcare sector. On total liabilities, it currently shows $78M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing TSHA with unrelated industries.